These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 8853465)

  • 1. Comparison of four bifunctional chelates for radiolabeling monoclonal antibodies with copper radioisotopes: biodistribution and metabolism.
    Rogers BE; Anderson CJ; Connett JM; Guo LW; Edwards WB; Sherman EL; Zinn KR; Welch MJ
    Bioconjug Chem; 1996; 7(4):511-22. PubMed ID: 8853465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation, biodistribution and dosimetry of copper-64-labeled anti-colorectal carcinoma monoclonal antibody fragments 1A3-F(ab')2.
    Anderson CJ; Schwarz SW; Connett JM; Cutler PD; Guo LW; Germain CJ; Philpott GW; Zinn KR; Greiner DP; Meares CF
    J Nucl Med; 1995 May; 36(5):850-8. PubMed ID: 7738663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor uptake and metabolism of copper-67-labeled monoclonal antibody chCE7 in nude mice bearing neuroblastoma xenografts.
    Novak-Hofer I; Zimmermann K; Maecke HR; Amstutz HP; Carrel F; Schubiger PA
    J Nucl Med; 1997 Apr; 38(4):536-44. PubMed ID: 9098198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of metabolites of 111In-diethylenetriaminepentaacetic acid-monoclonal antibodies and antibody fragments in vivo.
    Rogers BE; Franano FN; Duncan JR; Edwards WB; Anderson CJ; Connett JM; Welch MJ
    Cancer Res; 1995 Dec; 55(23 Suppl):5714s-5720s. PubMed ID: 7493333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Copper-64-labeled antibodies for PET imaging.
    Anderson CJ; Connett JM; Schwarz SW; Rocque PA; Guo LW; Philpott GW; Zinn KR; Meares CF; Welch MJ
    J Nucl Med; 1992 Sep; 33(9):1685-91. PubMed ID: 1517844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conjugation of monoclonal antibodies with TETA using activated esters: biological comparison of 64Cu-TETA-1A3 with 64Cu-BAT-2IT-1A3.
    Lewis MR; Boswell CA; Laforest R; Buettner TL; Ye D; Connett JM; Anderson CJ
    Cancer Biother Radiopharm; 2001 Dec; 16(6):483-94. PubMed ID: 11789025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maximum tolerated dose and large tumor radioimmunotherapy studies of 64Cu-labeled monoclonal antibody 1A3 in a colon cancer model.
    Connett JM; Buettner TL; Anderson CJ
    Clin Cancer Res; 1999 Oct; 5(10 Suppl):3207s-3212s. PubMed ID: 10541365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radioimmunotherapy with a 64Cu-labeled monoclonal antibody: a comparison with 67Cu.
    Connett JM; Anderson CJ; Guo LW; Schwarz SW; Zinn KR; Rogers BE; Siegel BA; Philpott GW; Welch MJ
    Proc Natl Acad Sci U S A; 1996 Jun; 93(13):6814-8. PubMed ID: 8692901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 67Cu-versus 131I-labeled Lym-1 antibody: comparative pharmacokinetics and dosimetry in patients with non-Hodgkin's lymphoma.
    DeNardo GL; Kukis DL; Shen S; DeNardo DA; Meares CF; DeNardo SJ
    Clin Cancer Res; 1999 Mar; 5(3):533-41. PubMed ID: 10100704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting strategies for cancer radiotherapy.
    Buchsbaum DJ; Rogers BE; Khazaeli MB; Mayo MS; Milenic DE; Kashmiri SV; Anderson CJ; Chappell LL; Brechbiel MW; Curiel DT
    Clin Cancer Res; 1999 Oct; 5(10 Suppl):3048s-3055s. PubMed ID: 10541342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preclinical evaluation of 67Cu-labeled intact and fragmented anti-colon carcinoma monoclonal antibody MAb35.
    Smith A; Alberto R; Blaeuenstein P; Novak-Hofer I; Maecke HR; Schubiger PA
    Cancer Res; 1993 Dec; 53(23):5727-33. PubMed ID: 8242629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microautoradiographic analysis of the normal organ distribution of radioiodinated single-chain Fv and other immunoglobulin forms.
    Yokota T; Milenic DE; Whitlow M; Wood JF; Hubert SL; Schlom J
    Cancer Res; 1993 Aug; 53(16):3776-83. PubMed ID: 8339291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of a direct method for technetium labeling intact and F(ab')2 1A3, an anticolorectal monoclonal antibody.
    Schwarz SW; Connett JM; Anderson CJ; Rocque PA; Philpott GW; Guo LW; Welch MJ
    Nucl Med Biol; 1994 May; 21(4):619-26. PubMed ID: 9234319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biodistribution study of 188Re-labeled trisuccin-HuCC49 and trisuccin-HuCC49deltaCh2 conjugates in athymic nude mice bearing intraperitoneal colon cancer xenografts.
    Safavy A; Khazaeli MB; Safavy K; Mayo MS; Buchsbaum DJ
    Clin Cancer Res; 1999 Oct; 5(10 Suppl):2994s-3000s. PubMed ID: 10541333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peptide linkers lead to modification of liver metabolism and improved tumor targeting of copper-67-labeled antibody fragments.
    Novak-Hofer I; Zimmermann K; Schubiger PA
    Cancer Biother Radiopharm; 2001 Dec; 16(6):469-81. PubMed ID: 11789024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biodistribution of monoclonal IgG1, F(ab')2, and Fab' in mice after intravenous injection. Comparison between anti-B cell (anti-Lyb8.2) and irrelevant (MOPC-21) antibodies.
    Holton OD; Black CD; Parker RJ; Covell DG; Barbet J; Sieber SM; Talley MJ; Weinstein JN
    J Immunol; 1987 Nov; 139(9):3041-9. PubMed ID: 3499463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of radiolabeled stabilized F(ab')2 fragments of monoclonal antiferritin in nude mouse model.
    Quadri SM; Lai J; Mohammadpour H; Vriesendorp HM; Williams JR
    J Nucl Med; 1993 Dec; 34(12):2152-9. PubMed ID: 8254403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biodistribution of iodine-125 and indium-111 labeled OV-TL 3 intact antibodies and F(ab')2 fragments in tumor-bearing athymic mice.
    Massuger LF; Boerman OC; Corstens FH; Verheijen RH; Claessens RA; Poels LG; van den Broek WJ; Kenemans P
    Anticancer Res; 1991; 11(6):2051-7. PubMed ID: 1776839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of copper-67- and iodine-125-labeled anti-CEA monoclonal antibody biodistribution in patients with colorectal tumors.
    Delaloye AB; Delaloye B; Buchegger F; Vogel CA; Gillet M; Mach JP; Smith A; Schubiger PA
    J Nucl Med; 1997 Jun; 38(6):847-53. PubMed ID: 9189128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A triglycine linker improves tumor uptake and biodistributions of 67-Cu-labeled anti-neuroblastoma MAb chCE7 F(ab')2 fragments.
    Zimmermann K; Gianollini S; Schubiger PA; Novak-Hofer I
    Nucl Med Biol; 1999 Nov; 26(8):943-50. PubMed ID: 10708309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.